Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have measurable lesions
Have recovered from prior chemotherapies
Have an estimated life expectancy of at least 12 weeks
Hepatic: total bilirubin less than or equal to 1.5 XULN; ATL/AST less than or equal to 2.0 x ULN (less than 5x if liver metastases are present)
Renal: serum creatinine less than or equal to 1.5XULN
Adequate bone marrow reserve: platelets greater than or equal to 75 x 109 /Liter (L) Criteria:
Have a second primary malignancy (except adequately treated nonmelanomatous skin cancer, or other cancer that is considered cured by surgical resection or radiation).
Anti-lymphoma therapy within the past 3 weeks
Unable to swallow tablets
Unable to discontinue use of carbamazepine, phenobarbital and phenytoin at least 14 days prior to study enrollment